April 16, 2024

Costaalegre Restaurant

Learn marketing business

Global Sepsis Diagnostics Markets, 2020-2021 & Forecast to 2025 by Assay, Cause, Product, Lab, and by Place with COVID-19 Related Sepsis Market Analysis and Forecasts – ResearchAndMarkets.com

4 min read

DUBLIN–(BUSINESS WIRE)–The “Sepsis Diagnostics – Global Markets by Assay, by Cause, by Product, by Lab, and by Place, with Executive and Consultant Guides and COVID-19 Related Sepsis Market Analysis and Forecasts 2020-2025” report has been added to ResearchAndMarkets.com’s offering.

The report forecasts the market size out to 2025.

Sepsis is killing over 45 million people a year with no definitive diagnostic in hand. And now the COVID Pandemic has increased the sepsis death toll.

The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life saving diagnostics can command a premium in the market, especially deaths related to COVID infections. Understand the different drivers of this huge global diagnostic market and where the opportunity lies.

Growth is coming from the basic factors but the COVID Pandemic has changed to market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnositic and the Genomics Revolution are merging to create new diagnostic opportunities.

Key Topics Covered:

1 Market Guides

1.1 Situation Analysis – COVID & Sepsis

1.2 Guide for Executives and Marketing Staff

1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

2.1 An Overview of Sepsis Diagnostics

2.1.1 Sepsis the medical emergency

2.1.2 Sepsis Diagnosis and Comorbidity

2.2 Market Definition

2.2.1 Market Size

2.2.2 Currency

2.2.3 Years

2.2.4 Microbiology

2.2.5 PCR

2.2.6 Immunoassay

2.2.7 Other Infectious Disease

2.2.8 Syndromic PoC

2.2.9 Biomarkers Molecular Diagnostics

2.2.10 Biomarkers Other

2.2.11 Limitations

2.3 Methodology

2.4 U.S. Medical Market and laboratory Testing – Perspective

2.4.1 U.S. Medicare Expenditures for Laboratory Testing

3 Sepsis – Current Science

3.1 What is Sepsis?

3.1.1 Organ Damage

3.1.2 Neonatal sepsis

3.1.3 Prognosis

3.2 Diagnosis

3.2.1 Infection Identification

3.2.2 Biomarkers

3.2.3 Differential diagnosis

3.2.4 The Cytokine Storm – Diagnostic Needs

3.3 Causes of Sepsis

3.3.1 Sepsis Progression

3.3.2 The Cytokine Storm – COVID and Other Situations

3.4 Prevalence

3.4.1 Impact of COVID on Sepsis Prevalence

4 Industry Overview

4.1 Players in a Dynamic Market

4.1.1 Academic Research Lab

4.1.2 Diagnostic Test Developer

4.1.3 Pharmaceutical/Reagent Supplier

4.1.4 Independent Testing Lab

4.1.5 Public National/Regional Lab

4.1.6 Hospital lab

4.1.7 Physician Lab

4.1.8 Audit Body

4.1.9 Certification Body

5 Market Trends

5.1 Factors Driving Growth

5.1.1 Increasing Prevalence

5.1.2 Antimicrobial Resistance

5.1.3 Increasing Diagnosis

5.1.4 Multiplex Diagnostics Impacts

5.1.5 The Aging World

5.1.6 COVID Market Impact

5.2 Factors Limiting Growth

5.2.1 The Cost Curve Shrinks the Market

5.2.2 The Diagnostics Dillemma

5.2.3 Adoption Lag and Cost Control

5.3 Diagnostic Technology Development

5.3.1 The Multiplex Opportunity

5.3.2 Shifting Role of Physicians in Diagnosis

5.3.3 Diagnostics Moves Out of the Lab

5.3.4 Biomarkers and Algorithms

5.3.5 Rapid Testing Changing Medical Practice

5.3.6 Genome Role and Big Data

5.3.7 The Next Five Years

6 Sepsis Diagnostics – Recent Developments

6.1 Recent Developments – Importance and How to Use This Section

6.1.1 Importance of These Developments

7 Profiles of Key Companies

7.1 Abbott Diagnostics

7.2 Abionic

7.3 Accel Diagnostics

7.4 Accelerate Diagnostics

7.5 Axis-Shield Diagnostics Ltd

7.6 Beckman Coulter Diagnostics

7.7 Becton, Dickinson and Company

7.8 Biocartis

7.9 bioMerieux Diagnostics

7.10 Bio-Rad Laboratories, Inc.

7.11 Bruker

7.12 Cube Dx

7.13 Curetis N.V. / Curetis GmbH

7.14 Cytovale

7.15 DNAe

7.16 EKF Diagnostics Holdings

7.17 GeneFluidics

7.18 GenMark Dx

7.19 Grifols

7.20 Immunexpress

7.21 Inflammatix

7.22 LightDeck Diagnostics

7.23 Linear Diagnostics

7.24 Luminex Corp

7.25 Mbio Diagnostics

7.26 Mobidiag

7.27 Nanomix

7.28 Qiagen Gmbh

7.29 Response Biomedical

7.30 Roche Molecular Diagnostics

7.31 SeLux Diagnostics

7.32 Septec

7.33 Siemens Healthineers

7.34 Sphingotec

7.35 T2 Biosystems

7.36 Thermo Fisher Scientific Inc

8 Sepsis Global Diagnostic Markets Overview

8.1 Sepsis Diagnostics – Global Market Overview by Country

8.2 Global Sepsis Diagnostics Markets Overview by Assay

8.3 Global Sepsis Diagnostics Markets Overview by Cause

8.4 Global Sepsis Diagnostics Markets Overview by Product

8.5 Global Sepsis Diagnostics Markets Overview by Lab

8.6 Global Sepsis Diagnostics Markets Overview by Place

9 Sepsis Diagnostic Market – by Assay

9.1 Sepsis Diagnostic – Microbiology

9.2 Sepsis Diagnostic – PCR

9.3 Sepsis Diagnostic – Immunoassay

9.4 Sepsis Diagnostic – Infectious Disease Other

9.5 Sepsis Diagnostic – Biomarker MDx

10 Global Sepsis Diagnostics Markets – By Cause

10.1 Sepsis Diagnostic – GastroIntestinal

10.2 Sepsis Diagnostic – Respiratory COVID-19

10.3 Sepsis Diagnostic – Respiratory Other

10.4 Sepsis Diagnostic – Neonatal

11 Global Sepsis Diagnostics Markets – By Product

11.1 Sepsis Diagnostic – Instrumentation

11.2 Sepsis Diagnostic – Consumables

11.3 Sepsis Diagnostic – Software & Service

12 Global Sepsis Diagnostics Markets – By Lab

12.1 Sepsis Diagnostic – In Lab

12.2 Sepsis Diagnostic – Point of Care

13 Global Sepsis Diagnostics Markets – By Place

13.1 Sepsis Diagnostic – Hospital

13.2 Sepsis Diagnostic – Other Place

14 Appendices

14.1 United States Medicare System: 2021 Clinical Laboratory Fees Schedule

Companies Mentioned

  • Abbott Diagnostics
  • Abionic
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocartis
  • bioMerieux Diagnostics
  • Bruker
  • Cube Dx
  • Curetis N.V. / Curetis GmbH
  • Cytovale
  • DNAe
  • EKF Diagnostics Holdings
  • GeneFluidics
  • GenMark Dx
  • Grifols
  • Immunexpress
  • Inflammatix
  • LightDeck Diagnostics
  • Linear Diagnostics
  • Luminex Corp
  • Mbio Diagnostics
  • Mobidiag
  • Nanomix
  • Qiagen Gmbh
  • Response Biomedical
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Septec
  • Siemens Healthineers
  • Sphingotec
  • T2 Biosystems
  • Thermo Fisher Scientific Inc

For more information about this report visit https://www.researchandmarkets.com/r/7d8c1d

costaalegrerestaurant.com | Newsphere by AF themes.